Details
| Stereochemistry | RACEMIC |
| Molecular Formula | C17H18F2O2 |
| Molecular Weight | 292.3204 |
| Optical Activity | ( + / - ) |
| Defined Stereocenters | 2 / 2 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CC[C@H]([C@H](C)C1=CC(F)=C(O)C=C1)C2=CC=C(O)C(F)=C2
InChI
InChIKey=RDVXUHOSYIBGBT-ZWNOBZJWSA-N
InChI=1S/C17H18F2O2/c1-3-13(12-5-7-17(21)15(19)9-12)10(2)11-4-6-16(20)14(18)8-11/h4-10,13,20-21H,3H2,1-2H3/t10-,13-/m1/s1
| Molecular Formula | C17H18F2O2 |
| Molecular Weight | 292.3204 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 2 / 2 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Bifluranol, a novel fluorinated bibenzyl anti-androgen, its chemistry and disposition in different animal species. | 1981-05 |
|
| Anti-prostatic activity of bifluranol, a fluorinated bibenzyl. | 1980 |
|
| Comparison of the novel bibenzyl bifluranol with diethystilboestrol: effect of aromatic fluorine substitution on metabolism [proceedings]. | 1978-06 |
Sample Use Guides
In Vivo Use Guide
Sources: https://doi.org/10.1002/pros.2990070403
Thirty five patients with bladder outflow obstruction received either Bifluranol 1.5 mg orally, t.d.s. or placebo in a double‐blind trial.
Route of Administration:
Oral
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:02:03 GMT 2025
by
admin
on
Mon Mar 31 18:02:03 GMT 2025
|
| Record UNII |
47602X79JF
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C242
Created by
admin on Mon Mar 31 18:02:03 GMT 2025 , Edited by admin on Mon Mar 31 18:02:03 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
100000085904
Created by
admin on Mon Mar 31 18:02:03 GMT 2025 , Edited by admin on Mon Mar 31 18:02:03 GMT 2025
|
PRIMARY | |||
|
47602X79JF
Created by
admin on Mon Mar 31 18:02:03 GMT 2025 , Edited by admin on Mon Mar 31 18:02:03 GMT 2025
|
PRIMARY | |||
|
3795
Created by
admin on Mon Mar 31 18:02:03 GMT 2025 , Edited by admin on Mon Mar 31 18:02:03 GMT 2025
|
PRIMARY | |||
|
C017070
Created by
admin on Mon Mar 31 18:02:03 GMT 2025 , Edited by admin on Mon Mar 31 18:02:03 GMT 2025
|
PRIMARY | |||
|
m1025
Created by
admin on Mon Mar 31 18:02:03 GMT 2025 , Edited by admin on Mon Mar 31 18:02:03 GMT 2025
|
PRIMARY | Merck Index | ||
|
12850912
Created by
admin on Mon Mar 31 18:02:03 GMT 2025 , Edited by admin on Mon Mar 31 18:02:03 GMT 2025
|
PRIMARY | |||
|
C77332
Created by
admin on Mon Mar 31 18:02:03 GMT 2025 , Edited by admin on Mon Mar 31 18:02:03 GMT 2025
|
PRIMARY | |||
|
CHEMBL2105524
Created by
admin on Mon Mar 31 18:02:03 GMT 2025 , Edited by admin on Mon Mar 31 18:02:03 GMT 2025
|
PRIMARY | |||
|
3026
Created by
admin on Mon Mar 31 18:02:03 GMT 2025 , Edited by admin on Mon Mar 31 18:02:03 GMT 2025
|
PRIMARY | |||
|
DTXSID30865725
Created by
admin on Mon Mar 31 18:02:03 GMT 2025 , Edited by admin on Mon Mar 31 18:02:03 GMT 2025
|
PRIMARY | |||
|
135219
Created by
admin on Mon Mar 31 18:02:03 GMT 2025 , Edited by admin on Mon Mar 31 18:02:03 GMT 2025
|
PRIMARY | |||
|
SUB05830MIG
Created by
admin on Mon Mar 31 18:02:03 GMT 2025 , Edited by admin on Mon Mar 31 18:02:03 GMT 2025
|
PRIMARY | |||
|
34633-34-6
Created by
admin on Mon Mar 31 18:02:03 GMT 2025 , Edited by admin on Mon Mar 31 18:02:03 GMT 2025
|
PRIMARY | |||
|
Bifluranol
Created by
admin on Mon Mar 31 18:02:03 GMT 2025 , Edited by admin on Mon Mar 31 18:02:03 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
TARGET -> INHIBITOR |
|
||
|
TARGET -> AGONIST |
IC50
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
|